...
首页> 外文期刊>Vaccine >Universal measles-mumps-rubella vaccination to new recruits and the incidence of mumps in the military
【24h】

Universal measles-mumps-rubella vaccination to new recruits and the incidence of mumps in the military

机译:通用麻疹-Mumps-Rubella接种新兵和军队腮腺炎的发生率

获取原文
获取原文并翻译 | 示例
           

摘要

In response to the resurgence of mumps, the Korean Armed Forces started the measles-mumps-rubella (MMR) vaccination to all new recruits regardless of prior vaccination history. We evaluated the effectiveness of the vaccination by comparing the incidence between the military and civilian populations before and after implementation of the new policy. The standardized incidence ratio of mumps in the military was 7.06 in the prevaccine period, which declined to 0.96 in the postvaccine period. Vaccine effectiveness was estimated at 86.4%. Incidence rate ratio was lower in the 1996-1998 birth cohort (BC) compared with 1989-1995 BC (0.10 vs. 0.55), suggesting higher effectiveness of vaccination in the 1996-1998 BC. Our data provide evidence for the use of the MMR vaccination in the prevention of mumps in high-risk adults. (C) 2017 Elsevier Ltd. All rights reserved.
机译:为了回应腮腺炎的复苏,无论现有疫苗接种历史如何,韩国武装部队都开始向所有新招生的麻疹碎片 - 风疹(MMR)接种。 通过比较新政策之前和之后的军事和平民群体之间的发病率,我们评估了疫苗接种的有效性。 在接受期间,军队的腮腺炎的标准化发生率比为7.06,在后续期间下降至0.96。 疫苗有效性估计为86.4%。 与1989-1995 BC(0.10与0.55)相比,1996 - 1998年的出生队列(BC)中发病率比率较低,表明1996 - 1998年BC疫苗的效力较高。 我们的数据提供了使用MMR疫苗接种在预防高风险成年人的腮腺炎中的证据。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号